Molecular at Home and Point of Care Testing for Infectious Diseases

Program Committee Moderator(s)

• 

  Heba Mostafa, MD. PhD. D(ABMM) (she/her/hers)

  Associate Professor of Pathology, Director of Molecular Virology
  Johns Hopkins Medical Institutions
  Baltimore, Maryland, United States

Co-Moderator (Early Career)(s)

• 

  Yi Ding, MD, PhD

  System and Core Laboratory Director, Molecular Diagnostics
  Geisinger Medical Center
  Danville, Pennsylvania, United States

Session

Description: This session will differentiate between at-home collections, at-home testing, and point-of-care testing and discuss each model's regulatory limitations, clinical integration and impact, and business perspective.

If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)

Title: Implementation of Molecular Infectious Diagnostics Test at the Point-of- Care (AMP 2020 Annual Meeting)
Click here to learn more.

Presentations:

• 10:15 AM – 10:45 AM PST

  Cost-Effectiveness, Economic, and Business Considerations for Point-ofCare, At Home, and Home Collection Testing
  

  Breakout Speaker: Kevin D. Frick, PhD (they/them/theirs) – Johns Hopkins Carey Business School
• 10:45 AM – 11:15 AM PST

  Integrating At-Home and Point-of-Care Testing into Clinical Care: Impacts on Physician Decision-Making in Real-World Settings
  

  Breakout Speaker: Jeremiah Hinson, MD, PhD (he/him/his) – Johns Hopkins Medicine
• 11:15 AM – 11:45 AM PST

  FDA Perspectives on Molecular at Home and Point of Care Testing for Infectious Diseases
  

  Breakout Speaker: Courtney H. Lias, PhD (she/her/hers) – FDA